NYSE · MAGN

Magnera Corporation

$13.71 +$0.45 (+3.39%) 1D After hours

Key Metrics

$472.06M
Market cap
P/E · TTM
$4.79B
Revenue · TTM
−$110.00M
Net income
EPS · TTM $-3.07
Dividend yield
Free cash flow $128.00M
Beta · 1Y 1.32
EBITDA · TTM $96.00M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 6
    The stock moved +9.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 6
  • Mar 27
    From its Feb 5 high, the share price fell 41%.

    Peak close $14.96 on Feb 5; trough close $8.89 on Mar 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -41%
  • Mar 20
    The stock moved -8.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 20

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$472.06M
Enterprise value$2.07B
Shares outstanding35.6M
52-wk range$7.82 – $15.52
Avg volume · 20D680.6K
Net cash −$1.60B
Book value / share$29.02
IndustryPaper Mills
ExchangeNYSE
About Magnera Corporation
IPO dateJun 1, 1972
Employees8500

Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.10
P/FCF3.69
EV/EBITDA21.54
EV/Sales0.43
Graham №

Profitability

Gross
Operating -2.1%
Net -2.3%
FCF 2.7%
ROE / ROIC -17.0% · -4.2%

Financial Health

Current ratio2.33
Quick ratio
Debt / equity1.83
Debt / EBITDA 19.78
Net cash −$1.60B
Working capital$802.00M

Cash Flow · TTM

Operating CF $185.00M
Capex −$57.00M
Free cash flow $128.00M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

1.4
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-28 · computed by TickerWolf from SEC filings